New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Spike D614G — A Candidate Vaccine Antigen Against Covid-19

Gregory C. Ippolito on LinkedIn: Human Antibodies Target Many Parts of Coronavirus Spike Protein

COVID-19/SARS-CoV-2 Resources

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

News & Comment Cellular & Molecular Immunology

Targets and strategies for vaccine development against SARS-CoV-2 - ScienceDirect

Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches [PeerJ]

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

Applications of genetic engineering in COVID-19 - ScienceDirect

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Vaccines, Free Full-Text

SARS-CoV-2 cell entry: structural & functional mechanism